A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

NCT02490930 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Anaplastic Astrocytoma

Interventions

DRUG: Fingolimod

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins